# ERTAPENEM

NDC: 42023-221
Generic name: ertapenem sodium
Labeler / Manufacturer: ENDO USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20181101

FDA application: NDA021337

## Active ingredients

- ERTAPENEM SODIUM: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-221"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-221
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41304b1d-7db4-468a-ab1d-04e56fb50de4